BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25551591)

  • 21. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 22. Lower cost strategies for triage of human papillomavirus DNA-positive women.
    Qiao YL; Jeronimo J; Zhao FH; Schweizer J; Chen W; Valdez M; Lu P; Zhang X; Kang LN; Bansil P; Paul P; Mahoney C; Berard-Bergery M; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
    Int J Cancer; 2014 Jun; 134(12):2891-901. PubMed ID: 24248915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women.
    Huchko MJ; Sneden J; Zakaras JM; Smith-McCune K; Sawaya G; Maloba M; Bukusi EA; Cohen CR
    PLoS One; 2015; 10(4):e0118568. PubMed ID: 25849627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India.
    Sahasrabuddhe VV; Bhosale RA; Kavatkar AN; Nagwanshi CA; Joshi SN; Jenkins CA; Shepherd BE; Kelkar RS; Sahay S; Risbud AR; Vermund SH; Mehendale SM
    Int J Cancer; 2012 Jan; 130(1):234-40. PubMed ID: 21387289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV-based cervical cancer screening in a population at high risk for HIV infection.
    Womack SD; Chirenje ZM; Gaffikin L; Blumenthal PD; McGrath JA; Chipato T; Ngwalle S; Munjoma M; Shah KV
    Int J Cancer; 2000 Jan; 85(2):206-10. PubMed ID: 10629079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda.
    Umulisa MC; Franceschi S; Baussano I; Tenet V; Uwimbabazi M; Rugwizangoga B; Heideman DAM; Uyterlinde AM; Darragh TM; Snijders PJF; Sayinzoga F; Clifford GM
    BMC Womens Health; 2018 Apr; 18(1):59. PubMed ID: 29699549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study.
    Zhang HY; Tiggelaar SM; Sahasrabuddhe VV; Smith JS; Jiang CQ; Mei RB; Wang XG; Li ZA; Qiao YL
    Asian Pac J Cancer Prev; 2012; 13(1):91-6. PubMed ID: 22502720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.
    Zhao FH; Lewkowitz AK; Chen F; Lin MJ; Hu SY; Zhang X; Pan QJ; Ma JF; Niyazi M; Li CQ; Li SM; Smith JS; Belinson JL; Qiao YL; Castle PE
    J Natl Cancer Inst; 2012 Feb; 104(3):178-88. PubMed ID: 22271765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A study of cervical cancer screening algorithms].
    Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Sequential Rounds of Cervical Cancer Screening on Management of HPV-positive Women: A 15-year Population-based Cohort Study from China.
    Xu XQ; Rezhake R; Hu SY; Chen F; Zhang X; Pan QJ; Zhang WH; Ma JF; Qiao YL; Zhao FH; Cruickshank M
    Cancer Prev Res (Phila); 2021 Mar; 14(3):363-372. PubMed ID: 33303694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CareHPV cervical cancer screening demonstration in a rural population of north India.
    Labani S; Asthana S; Sodhani P; Gupta S; Bhambhani S; Pooja B; Lim J; Jeronimo J
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():75-9. PubMed ID: 24685404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies.
    Fokom-Domgue J; Combescure C; Fokom-Defo V; Tebeu PM; Vassilakos P; Kengne AP; Petignat P
    BMJ; 2015 Jul; 351():h3084. PubMed ID: 26142020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study.
    Sørbye SW; Fismen S; Gutteberg TJ; Mortensen ES; Skjeldestad FE
    BMJ Open; 2016 Aug; 6(8):e011981. PubMed ID: 27515759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review and meta-analysis of studies evaluating the performance of point-of-care tests for human papillomavirus screening.
    Kelly H; Mayaud P; Segondy M; Pant Pai N; Peeling RW
    Sex Transm Infect; 2017 Dec; 93(S4):S36-S45. PubMed ID: 29223961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical Cancer Screening via Visual Inspection With Acetic Acid and Lugol Iodine for Triage of HPV-Positive Women.
    Wang S; Dang L; Liu S; Rezhake R; Yan H; Duan X; Zhang L; Zhang L; Zhang L; Su M; Guo F; Yan C; Liu M; Cao X; Sun M; Qiao Y; Zhao F
    JAMA Netw Open; 2024 Mar; 7(3):e244090. PubMed ID: 38551562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.
    Blossom DB; Beigi RH; Farrell JJ; Mackay W; Qadadri B; Brown DR; Rwambuya S; Walker CJ; Kambugu FS; Abdul-Karim FW; Whalen CC; Salata RA
    J Med Virol; 2007 Jun; 79(6):758-65. PubMed ID: 17457908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of human papilloma virus testing in primary cervical cancer screening in rural Madagascar].
    Dumont A; Bessières N; Razafindrafara G; Ravit M; Benbassa A
    Rev Epidemiol Sante Publique; 2019 Apr; 67(2):120-125. PubMed ID: 30448093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and risk factors for cervical intraepithelial neoplasia among HIV-infected women.
    Teixeira NC; Araújo AC; Correa CM; Lodi CT; Lima MI; Carvalho Nde O; Castillo DM; Melo VH
    Braz J Infect Dis; 2012; 16(2):164-9. PubMed ID: 22552459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.